Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding diaphragm changes in patients awaiting lung transplants

Official title: Diaphragm Structure and Pathobiology in Patients Being Bridged to Lung Transplant

Run by University Health Network, Toronto · NCT03667027 · Data updated 2026-11-12

This study looks at how different breathing support methods affect the diaphragm in patients waiting for lung transplants to find ways to reduce diaphragm damage.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto)
StatusRecruiting
StartedApril 1, 2019
Main results expectedAugust 30, 2025
Study endsDecember 30, 2025
Registry record updatedDecember 11, 2024
Trial IDNCT03667027 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients receiving respiratory support as a bridge to lung transplantation who are formally listed for transplantation.

Probably not a fit

Patients with a history of neuromuscular disorders or those who have received invasive mechanical ventilation for more than 48 hours in the past four weeks may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize the structural and functional changes in the diaphragm of patients who are being bridged to lung transplantation using mechanical ventilation or extracorporeal life support. It investigates how different respiratory support methods impact diaphragm injury and dysfunction, which can complicate weaning from mechanical ventilation. By employing bedside ultrasound to measure diaphragm thickness, the study seeks to correlate these ultrasound findings with histological changes observed in diaphragm tissues. The ultimate goal is to identify strategies to minimize diaphragm injury during respiratory support.

Why it matters

Potential benefit: If successful, this study could lead to improved methods for preserving diaphragm function in patients awaiting lung transplants, enhancing their recovery and weaning from mechanical ventilation.

How similar studies have gone: While diaphragm injury during mechanical ventilation is a recognized issue, this specific approach using ultrasound to correlate structural changes with histological data is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (Cases):

* Receiving a respiratory support modality as a bridge to lung transplantation
* Formally listed for transplantation

Inclusion Criteria (Control Group 1):

\- Undergoing lung transplantation for either obstructive or restrictive lung disease

Inclusion Criteria (Control Group 2):

\- Undergoing elective thoracic surgery without any prior history of chronic pulmonary parenchymal disease

Exclusion Criteria (Cases and Controls):

* Previously diagnosed with neuromuscular disorder
* Received invasive mechanical ventilation for \>48 hours in the preceding four weeks
* Thoracic cage deformity

Where it's running

  • Toronto General Hospital
    Toronto, Canada
    Recruiting

Study contacts

  • Principal investigator: Ewan Goligher, MD, PhD — University Health Network, Toronto
  • Study coordinator: Rongyu (Cindy) Jin
  • Email: rongyu.jin@uhn.ca
  • Phone: 416-340-4800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.